Longeveron, Inc. (LGVN)
2.435
-0.04
(-1.81%)
USD |
NASDAQ |
Oct 12, 16:00
2.435
0.00 (0.00%)
After-Hours: 16:51
Longeveron Max Drawdown (5Y) : 99.94% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.94% |
| August 31, 2026 | 99.89% |
| July 31, 2026 | 99.89% |
| June 30, 2026 | 99.89% |
| May 31, 2026 | 99.89% |
| April 30, 2026 | 99.89% |
| March 31, 2026 | 99.89% |
| February 28, 2026 | 99.88% |
| January 31, 2026 | 99.88% |
| December 31, 2025 | 99.88% |
| November 30, 2025 | 99.86% |
| October 31, 2025 | 99.84% |
| September 30, 2025 | 99.84% |
| August 31, 2025 | 99.84% |
| July 31, 2025 | 99.81% |
| June 30, 2025 | 99.81% |
| May 31, 2025 | 99.81% |
| April 30, 2025 | 99.81% |
| March 31, 2025 | 99.81% |
| February 28, 2025 | 99.81% |
| January 31, 2025 | 99.81% |
| December 31, 2024 | 99.81% |
| November 30, 2024 | 99.81% |
| October 31, 2024 | 99.81% |
| September 30, 2024 | 99.81% |
| Date | Value |
|---|---|
| August 31, 2024 | 99.81% |
| July 31, 2024 | 99.81% |
| June 30, 2024 | 99.81% |
| May 31, 2024 | 99.75% |
| April 30, 2024 | 99.61% |
| March 31, 2024 | 99.26% |
| February 29, 2024 | 98.79% |
| January 31, 2024 | 98.73% |
| December 31, 2023 | 97.04% |
| November 30, 2023 | 96.10% |
| October 31, 2023 | 96.10% |
| September 30, 2023 | 94.92% |
| August 31, 2023 | 94.56% |
| July 31, 2023 | 94.04% |
| June 30, 2023 | 94.04% |
| May 31, 2023 | 94.04% |
| April 30, 2023 | 94.04% |
| March 31, 2023 | 93.71% |
| February 28, 2023 | 93.36% |
| January 31, 2023 | 93.36% |
| December 31, 2022 | 93.36% |
| November 30, 2022 | 92.25% |
| October 31, 2022 | 91.91% |
| September 30, 2022 | 91.25% |
| August 31, 2022 | 88.69% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Oncolytics Biotech, Inc. | 92.83% |
| Sangamo Therapeutics, Inc. | 99.68% |
| Sarepta Therapeutics, Inc. | 93.33% |
| Anixa Biosciences, Inc. | 70.17% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -64.16 |
| Beta (5Y) | -0.1918 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 267.5% |
| Historical Sharpe Ratio (5Y) | -0.247 |
| Historical Sortino (5Y) | -1.202 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 50.80% |